Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
02/2010
02/23/2010CA2361397C Process for drying protein crystals
02/23/2010CA2344173C Immunogenic liposome compositions
02/23/2010CA2315277C Pharmaceutical compositions containing the long pentraxin ptx3
02/23/2010CA2303390C Lkta deletion mutant of p. haemolytica
02/23/2010CA2294760C Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin
02/23/2010CA2257852C Transgenic non-human mammals with progressive neurologic disease
02/23/2010CA2198899C Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
02/23/2010CA2138999C Cloning and expression of gonadotropin-releasing hormone receptor
02/23/2010CA2125449C Vector and mammalian cell line having improved productivity
02/18/2010WO2010019717A2 Combination therapy of hiv fusion/entry inhibitors targeting gp41
02/18/2010WO2010019442A1 Production, formulation, and uses of stable liquid harpin protein formulations
02/18/2010WO2010019262A2 Polyvalent vaccine
02/18/2010WO2010019261A1 Use of gdf traps to increase red blood cell levels
02/18/2010WO2010019120A1 S0x9, prostaglandin d2 and retinoic acid for treating pigmentary conditions and melanoma
02/18/2010WO2010019103A1 The use of wnt5-a peptide derivates for the treatment of melanoma and gastric cancer
02/18/2010WO2010018870A1 Polypeptide marker for diagnosis of arteriosclerosis, method for detection of arteriosclerosis by using the maker or the like, and kit for diagnosis of arteriosclerosis
02/18/2010WO2010018859A1 Modified biotin-binding protein
02/18/2010WO2010018847A1 Recombinant protein-s composition
02/18/2010WO2010018845A1 Method for promotion of branch formation, dwarfing, sterility and promotion of multiple flower bud formation of plant
02/18/2010WO2010018652A1 Agent for promoting neuronal differentiation and method therefor
02/18/2010WO2010018444A2 An expression vector and a method thereof
02/18/2010WO2010018384A1 T-cell antigen peptide from allergen for stimulation of il-10 production
02/18/2010WO2010018378A2 Ragweed peptides for vaccine
02/18/2010WO2010018182A1 Peptidic and peptidomimetic compounds for regulating autophagy
02/18/2010WO2010018136A1 Minigene comprising htpa signal peptide, t-cell epitopes, e. coli ltb and furin sensitive linkers
02/18/2010WO2010017819A1 EFFICIENT CELL CULTURE SYSTEM FOR HEPATITIS C VIRUS GENOTYPE 7a
02/18/2010WO2010017818A1 Efficient cell culture system for hepatitis c virus genotype 2b
02/18/2010WO2010017653A1 Gq protein competitive inhibitory polypeptides, preparation methods and uses thereof
02/18/2010WO2010017598A1 Anti-il-12/il-23 antibodies
02/18/2010WO2009155324A3 Pigf-1 assay and kits and components thereof
02/18/2010WO2009134962A3 Claudin-4 binding peptides, compositions and methods of use
02/18/2010WO2009126719A3 Commensal bacteria as signal mediators within a mammalian host
02/18/2010WO2009123982A3 Transiently buffered lactobacillus preparations and use thereof
02/18/2010WO2009120893A3 Polypeptide-polymer conjugates and methods of use thereof
02/18/2010WO2009118734A9 Coral-derived collagen and methods of farming same
02/18/2010WO2009113814A3 Protein marker for early diagnosis of liver cancer
02/18/2010WO2009108406A3 Engineered bacteriophages as adjuvants for antimicrobial agents and compositions and methods of use thereof
02/18/2010WO2009108307A3 Diagnostic uses of anti-h8 monoclonal antibodies
02/18/2010WO2009037402A9 Hpiv-2 variants and medical applications thereof
02/18/2010WO2004099390A3 Molecules for disease detection and treatment
02/18/2010US20100043083 Insect chemosensory receptors and methods of use thereof
02/18/2010US20100041875 Modified gp140 envelope polypeptides of hiv-1 isolates, compositions, stabilized trimeric coplexes, and uses thereof
02/18/2010US20100041872 Glycerol linked pegylated sugars and glycopeptides
02/18/2010US20100041871 Preparation of Canola Protein Isolate from Canola Oil Seeds ("Blendertein")
02/18/2010US20100041870 Lyophilization above collapse
02/18/2010US20100041868 Conserved neisserial antigens
02/18/2010US20100041827 Multilayer binding; lamellar surface structure containing at least two binding compounds is assembled under conditions in which the binding compounds self-regulate in or on the lamellar structure; organized mobile multifunctional conjugate (OMMC) assembly
02/18/2010US20100041826 Multilayer binding; lamellar surface structure containing at least two binding compounds is assembled under conditions in which the binding compounds self-regulate in or on the lamellar structure; organized mobile multifunctional conjugate (OMMC) assembly
02/18/2010US20100041617 Modulating mxa expression
02/18/2010US20100041612 Fragments of the Glucagon-Like Peptide-1 and Uses Thereof
02/18/2010US20100041611 Rapid Isolation of Osteoinductive Protein Mixtures From Mammalian Bone Tissue
02/18/2010US20100041610 Insecticidal toxin complex fusion protiens
02/18/2010US20100041609 Interleukin-1 receptor antagonists, compositions, and methods of treatment
02/18/2010US20100041605 Use of VEGF-C or VEGF-D in Reconstructive Surgery
02/18/2010US20100041604 Novel antiviral peptides against influenza virus
02/18/2010US20100041597 Peptides targeted to protein kinase c isoforms and uses thereof
02/18/2010US20100041596 Amelioration of Inflammatory Arthritis By Targeting the Pre-ligand Assembly Domain (Plad) of Tumor Necrosis Factor Receptors
02/18/2010US20100041595 Bone morphogenetic protein 3 and osteogenic devices and pharmaceutical products containing thereof
02/18/2010US20100041586 Method of improving efficacy of biological response-modifying proteins and the exemplary muteins
02/18/2010US20100041153 Expression of Proteins in E. Coli
02/18/2010US20100041147 Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation
02/18/2010US20100041144 Mammalian Cytokine; Related Reagents
02/18/2010US20100041142 Anti-apoptotic gene scc-s2 and diagnostic and therapeutic uses thereof
02/18/2010US20100041139 Juvenile hemochromatosis gene (HFE2A), expression products and uses thereof
02/18/2010US20100041138 IL-17 homologous polypeptides and therapeutic uses thereof
02/18/2010US20100041136 Connective Tissue Growth Factor-2
02/18/2010US20100041098 Modified clostridial toxins with altered targeting capabilities for clostridial toxin target cells
02/18/2010US20100041096 Carcinostatic method using BRCA1-BARD1 pathway
02/18/2010US20100041075 Tuberculosis Diagnostic Test
02/18/2010US20100041074 Pharmaceutical composition comprising anti-grp78 antibody as active ingredient
02/18/2010US20100041073 Two helix binders
02/18/2010US20100041072 Process for identifying a ligand that binds to the nep binding site for the smr1 pentapeptide
02/18/2010US20100041071 Method for determination of molecular weight of hyaluronic acid
02/18/2010US20100041060 Iron-regulating protein-2(irp-2) as a diagnostic for neurodegenerative disease
02/18/2010US20100041028 Zinc finger binding domains for GNN
02/18/2010US20100041022 Novel assay for the separation and quantification of hemagglutinin antigens
02/18/2010US20100041012 Rationally designed antibodies
02/18/2010US20100040862 Three-Dimensional Structure of Functional Material
02/18/2010US20100040754 Protein having sweetness
02/18/2010US20100040676 Polycistronic hiv vector constructs
02/18/2010US20100040650 Virus-Like paramyxovirus particles and vaccines
02/18/2010US20100040645 In vivo ctl elicitation by heat shock protein fusion proteins maps to a discrete domain and is cd4+ t cell-independent
02/18/2010US20100040644 Methods for preparing immunogenic conjugates
02/18/2010US20100040643 Flavivirus immunogens and methods of use
02/18/2010US20100040640 Expression, purification and uses of a plasmodium falciparum liver stage antigen 1 polypeptide
02/18/2010US20100040639 Methods of inducing il-10 production
02/18/2010US20100040634 Methods and compositions for modulating hgf/met
02/18/2010US20100040627 Baff receptor (bcma), an immunoregulatory agent
02/18/2010US20100040624 Human Tumor Necrosis Factor TR21 and Methods Based Thereon
02/18/2010US20100040623 Neuritogenic and neuronal survival promoting peptides derived from the family of s-100 proteins
02/18/2010US20100040621 Novel polpeptide and use thereof
02/18/2010US20100040602 Antibodies against Human Cytimegalovirus (HCMV)
02/18/2010US20100040591 Native potato protein isolates
02/18/2010US20100040578 Malignant Tumor Cell Suppressor Protein, Malignant Tumor Cell Suppressor Gene, Maligant Tumor Cell Suppressive Viral Vector, and Kit Using the Same
02/18/2010US20100040542 Chelator conjugates
02/18/2010US20100040539 Vector System
02/18/2010CA2736580A1 An expression vector and a method thereof
02/18/2010CA2734389A1 S0x9, prostaglandin d2 and retinoic acid for treating pigmentary conditions and melanoma
02/18/2010CA2734379A1 Ragweed peptides for vaccine
02/18/2010CA2734335A1 Human antibodies that bind lymphocyte activation gene-3 (lag-3), and uses thereof
1 ... 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 ... 2916